Clinical studies have shown elevated serum OPG levels in cardiovascular diseases[25–28,44], and it is suggested that increased serum OPG levels in humans may be caused by a self-defensive compensatory response to inflammation. Here, TNFRSF11B is linked to cardiovascular disorder.